Effects of Gadolinium Deposition in the Brain on Motor or Behavioral Function: A Mouse Model
Effects of Gadolinium Deposition in the Brain on Motor or Behavioral Function: A Mouse Model
复制标题
DOI:
10.1148/radiol.2021210892
复制
发表时间:
2021-11-01
期刊:
影响因子:
19.7
通讯作者:
Kiryu, Shigeru
中科院分区:
文献类型:
--
作者:
Akai, Hiroyuki;Miyagawa, Kazuya;Kiryu, Shigeru
Background: Recent studies showing gadolinium deposition in multiple organs have raised concerns about the safety of gadolinium-based contrast agents (GBCAs).Purpose: To explore whether gadolinium deposition in brain structures will cause any motor or behavioral alterations.Materials and Methods: This study was performed from July 2019 to December 2020. Groups of 17 female BALB/c mice were each repeatedly injected with phosphate-buffered saline (control group, group A), a macrocyclic GBCA (group B), or a linear GBCA (group C) for 8 weeks (5 mmol per kilogram of bodyweight per week for GBCAs). Brain MRI studies were performed every other week to observe the signal intensity change caused by the gadolinium deposition. After the injection period, rotarod performance test, open field test, elevated plus-maze test, light-dark anxiety test, locomotor activity assessment test, passive avoidance memory test, Y-maze test, and forced swimming test were performed to assess the locomotor abilities, anxiety level, and memory. Among-group differences were compared by using one-way or two-way factorial analysis of variance with Tukey post hoc testing or Dunnett post hoc testing.Results: Gadolinium deposition in the bilateral deep cerebellar nuclei was confirmed with MRI only in mice injected with a linear GBCA. At 8 weeks, contrast ratio of group C (0.11; 95% CI: 0.10, 0.12) was higher than that of group A (-2.1 x 10(-3); 95% CI: -0.011, 7.5 x 10(-)(3); P < .001) and group B (2.7 x 10(-)(4); 95% CI: -8.2 x 10(-3), 8.7 x 10(-3); P < .001). Behavioral analyses showed that locomotor abilities, anxiety level, and long-term or short-term memory were not different in mice injected with linear or macrocyclic GBCAs.Conclusion: No motor or behavioral alterations were observed in mice with brain gadolinium deposition. Also, the findings support the safety of macrocyclic gadolinium-based contrast agents. (C) RSNA, 2021